Cardiac Output Assessment by Using Saline Contrast Injection

NCT04310904 | Unknown

• 1 other identifier: PI2018_843_0057
• Study Type: observational
• Target: 65
• Locations: 1 country
• Sites: 1

Brief Summary

Cardiac output (CO) assessment is one of the cornerstone of hemodynamic evaluation in ICU patients. CO is usually measured using invasive methods or non-invasive methods. Thermodilution is considered as the gold standard for CO assessment. Cardiac Doppler as well demonstrated to be accurate but needs manipulations and good knowledge and skills. The investigators developed a new technique using injection of agitated saline solution to evaluate CO without any manual measurement and then observer independent.

Conditions

Echocardiography

Keywords

echocardiography; Doppler cardiac output; contrast; thermodilution; agitated saline; ICU

Outcome Measures

Primary Outcomes (1)

• variation of cardiac output assessment (CO)

  correlation will be done between contrast and the reference method cardiac Doppler method.

  day 0

Secondary Outcomes (1)

• variation of cardiac output assessment (CO) in patients with a swan gaz catheter

  day 0

Study Arms (1)

ICU cardiac output (CO) assessment patients

all ICU patients intubated/ventilated with a central line and an arterial catheter who need trans esophageal echocardiography examination with a saline contrast test.

Other: contrast assessment of cardiac output (CO); Other: cardiac Doppler technique

Interventions

contrast assessment of cardiac output (CO) OTHER

Patients hospitalized in ICU will be included if they need a trans esophageal echocardiographic evaluation and a research of intra cardiac shunt (using a saline contrast test). Patients with Swan Ganz catheter will be included as well. Cardiac output will be measured using cardiac Doppler. Simultaneously, 4.5 ml of saline with 0.5 ml of air will be agitated to have a contrast solution. This solution will be injected as usual and echocardiographic imaging will be recorded. These imaging will be analyzed off-line and CO will be calculated with an algorithm previously developed and compared with the reference method. In case of swan ganz catheter, the cardiac output will be also measured using the thermodilution technique.

ICU cardiac output (CO) assessment patients

cardiac Doppler technique OTHER

Patients hospitalized in ICU will be included if they need a trans esophageal echocardiographic evaluation and a research of intra cardiac shunt (using a saline contrast test). Patients with Swan Ganz catheter will be included as well. Cardiac output will be measured using cardiac Doppler. Simultaneously, 4.5 ml of saline with 0.5 ml of air will be agitated to have a contrast solution. This solution will be injected as usual and echocardiographic imaging will be recorded. These imaging will be analyzed off-line and CO will be calculated with an algorithm previously developed and compared with the reference method. In case of swan ganz catheter, the cardiac output will be also measured using the thermodilution technique.

ICU cardiac output (CO) assessment patients

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

all ICU patients intubated/ventilated with a central line and an arterial catheter who need trans esophageal echocardiography examination with a saline contrast test.

You may qualify if:

• all ICU patients intubated/ventilated with a central line and an arterial catheter who need trans esophageal echocardiography examination with a saline contrast test.

You may not qualify if:

• patients under 18 years old
• pregnant patients
• moribund patients

Sponsors & Collaborators

• Centre Hospitalier Universitaire, Amiens: lead

Study Sites (1)

CHU Amiens

Amiens, 80480, France

RECRUITING

Central Study Contacts

Michel Slama, Pr

CONTACT

(33)3 22 08 78 41; slama.michel@chu-amiens.fr

Julien Maizel, Pr

CONTACT

(33)3 22 08 78 07; maizel.julien@chu-amiens.fr

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: March 13, 2020
• First Posted: March 17, 2020
• Study Start: March 10, 2020
• Primary Completion: March 1, 2024
• Study Completion: March 1, 2024
• Last Updated: May 10, 2023

Record last verified: 2023-05

Data Sharing

• IPD Sharing: Will not share

Locations

FR (1)